BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Crit Care Med. Mar 9, 2026; 15(1): 112265
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.112265
Death in patients with immune-mediated inflammatory diseases in the intensive care unit: First week data
Ilia S Avrusin, Natalia N Abramova, Liudmila A Firsova, Yury S Aleksandrovich, Dmitry O Ivanov, Mikhail M Kostik
Ilia S Avrusin, Mikhail M Kostik, Hospital Pediatrics, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Sankt-Peterburg, Russia
Natalia N Abramova, Yury S Aleksandrovich, Department of Anestesiology, Reanimatology and Emergency Pediatrics, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Sankt-Peterburg, Russia
Liudmila A Firsova, Propaedeutics of Childhood Diseases, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Sankt-Peterburg, Russia
Dmitry O Ivanov, Department of Neonatology, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Sankt-Peterburg, Russia
Co-first authors: Ilia S Avrusin and Natalia N Abramova.
Author contributions: Avrusin IS, Abramova NN, and Kostik MM contributed to conceptualization, writing, review, and editing; Avrusin IS and Abramova NN contributed equally to this article as co-first authors; Ivanov DO, Aleksandrovich Yu S, and Kostik MM contributed to methodology; Avrusin IS and Firsova LA contributed to software, resources, data curation, and validation; Avrusin IS and Kostik MM contributed to formal analysis; Abramova NN and Firsova LA contributed to investigation and visualization; Avrusin IS, Aleksandrovich YS, and Kostik MM contributed to writing original draft, funding, supervision, and project administration; and all authors have read and agreed to the published version of the manuscript.
Institutional review board statement: The study protocol was approved by the local Ethics Committee of Saint Petersburg State Pediatric Medical University on March 22, 2021, approve No. 03/09.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Corresponding author: Mikhail M Kostik, MD, PhD, Professor, Hospital Pediatrics, Saint Petersburg State Pediatric Medical University, Lytovskaya 2, Saint Petersburg 194100, Sankt-Peterburg, Russia. kost-mikhail@yandex.ru
Received: July 23, 2025
Revised: September 10, 2025
Accepted: November 27, 2025
Published online: March 9, 2026
Processing time: 221 Days and 2 Hours
Core Tip

Core Tip: Systemic immune-mediated inflammatory diseases can be severe in both course and complications, quite often requiring intensive care unit admission and, in some cases, leading to death. For such patients, careful observation and dynamic monitoring of their condition, along with risk assessment, is critical. The risk factors for a lethal outcome during the first week of intensive care unit stay included signs of hemophagocytosis, progressive decline in the Glasgow Coma Scale, increasing Sequential Organ Failure Assessment scores, and persistent high C-reactive protein levels. Monitoring of these parameters may help to timely identify the patients at high risk of lethal outcome, allowing for the prompt prescription of appropriate treatment.